Safety and Efficacy of Arimoclomol in Patients With Early Amyotrophic Lateral Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Lancet Neurol 2024 Jul 01;23(7)687-699, M Benatar, T Hansen, D Rom, MA Geist, T Blaettler, W Camu, M Kuzma-Kozakiewicz, LH van den Berg, RJ Morales, A Chio, PM Andersen, PF Pradat, D Lange, P Van Damme, G Mora, M Grudniak, M Elliott, S Petri, N Olney, S Ladha, NA Goyal, T Meyer, MG Hanna, C Quinn, A Genge, L Zinman, D Jabari, C Shoesmith, AC Ludolph, C Neuwirth, S Nations, JM Shefner, MR Turner, J Wuu, R Bennett, H Dang, C SundgreenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.